https://www.selleckchem.com/pr....oducts/semaglutide.h
Exploratory outcomes of health-related quality-of-life patient-reported outcomes will be collected. Hospitalised patients with laboratory-confirmed COVID-19 will be recruited. This study was approved by the University of Utah Institutional Review Board (IRB_0013292), approved by the US FDA under Investigational New Drug (No 23369) and is registered on ClinicalTrials.gov. Results will be disseminated via peer-reviewed publications and conference presentations. NCT04497389; Pre-results. NCT04497389; Pre-results. Most patients are unaw
Like
Comment
Share
